Mutation of Ser1574 (C1 site) abolished forskolin-mediated enhancement of Cav1.2 channel activity, suggesting it is a potential site for PKA-mediated modulation.
Ser(1574) in the carboxyl terminal region of the α1C-subunit of the cardiac L-type Ca2+ channel is identified as a potential key site for PKA-mediated modulation.
Cardiac L-type Ca(2+) channels are modulated by phosphorylation by protein kinase A (PKA). To explore the PKA-targeted phosphorylation site(s), five potential phosphorylation sites in the carboxyl (COOH) terminal region of the α1C-subunit of the guinea pig Cav1.2 Ca(2+) channel were mutated by replacing serine (S) or threonine (T) residues with alanine (A): S1574A (C1 site), S1626A (C2), S1699A (C3), T1908A, (C4), S1927A (C5), and their various combinations. The wild-type Ca(2+) channel activity was enhanced three- to fourfold by the adenylyl cyclase activator forskolin (Fsk, 5 μM), and that of mutants at C3, C4, C5, and combination of these sites was also significantly increased by Fsk. However, Fsk did not modulate the activity of the C1 and C2 mutants and mutants of combined sites involving the C1 site. Three peptides of the COOH-terminal tail of α1C, termed CT1 corresponding to amino acids (aa) 1509-1789, containing sites C1-3, CT2 (aa 1778-2003, containing sites C4 and C5), and CT3 (aa 1942-2169), were constructed, and their phosphorylation by PKA was examined. CT1 and CT2, but not CT3, were phosphorylated in vitro by PKA. Three CT1 mutants at two sites of C1-C3 were also phosphorylated by PKA, but the mutant at all three sites was not. The CT2 mutant at the C4 site was phosphorylated by PKA, but the mutant at C5 sites was not. These results suggest that Ser(1574) (C1 site) may be a potential site for the channel modulation mediated by PKA.
Minobe et al. (Thu,) reported a other. Mutation of potential phosphorylation sites (e.g., S1574A) vs. Wild-type Ca(2+) channel was evaluated on Channel activity modulation by forskolin and phosphorylation by PKA. Mutation of Ser1574 (C1 site) abolished forskolin-mediated enhancement of Cav1.2 channel activity, suggesting it is a potential site for PKA-mediated modulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: